English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 109 | Tables: 110 | Medical Care
The global Targeted Alpha-particle Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The North American market for Targeted Alpha-particle Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Targeted Alpha-particle Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Targeted Alpha-particle Therapy in Immunotherapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Targeted Alpha-particle Therapy include Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Targeted Alpha-particle Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Alpha-particle Therapy. The Targeted Alpha-particle Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted Alpha-particle Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Alpha-particle Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bayer
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
Fusion Pharmaceuticals(AstraZeneca)
AlphaGen Therapeutics
Segment by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Segment by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Targeted Alpha-particle Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Actinium-225
1.2.3 Astatine-211
1.2.4 Lead-212
1.2.5 Bismuth-213
1.2.6 Others
1.3 Market by Application
1.3.1 Global Targeted Alpha-particle Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Immunotherapy
1.3.3 Peritoneal Carcinomas
1.3.4 Bone Metastases
1.3.5 Leukaemia
1.3.6 Melanomas
1.3.7 Solid Tumours
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Alpha-particle Therapy Market Perspective (2021–2032)
2.2 Global Targeted Alpha-particle Therapy Growth Trends by Region
2.2.1 Global Targeted Alpha-particle Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Targeted Alpha-particle Therapy Historic Market Size by Region (2021–2026)
2.2.3 Targeted Alpha-particle Therapy Forecasted Market Size by Region (2027–2032)
2.3 Targeted Alpha-particle Therapy Market Dynamics
2.3.1 Targeted Alpha-particle Therapy Industry Trends
2.3.2 Targeted Alpha-particle Therapy Market Drivers
2.3.3 Targeted Alpha-particle Therapy Market Challenges
2.3.4 Targeted Alpha-particle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Alpha-particle Therapy Players by Revenue
3.1.1 Global Top Targeted Alpha-particle Therapy Players by Revenue (2021–2026)
3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Targeted Alpha-particle Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Targeted Alpha-particle Therapy Revenue
3.4 Global Targeted Alpha-particle Therapy Market Concentration Ratio
3.4.1 Global Targeted Alpha-particle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Alpha-particle Therapy Revenue in 2025
3.5 Global Key Players of Targeted Alpha-particle Therapy Head Offices and Areas Served
3.6 Global Key Players of Targeted Alpha-particle Therapy, Products and Applications
3.7 Global Key Players of Targeted Alpha-particle Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Targeted Alpha-particle Therapy Breakdown Data by Type
4.1 Global Targeted Alpha-particle Therapy Historic Market Size by Type (2021–2026)
4.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (2027–2032)
5 Targeted Alpha-particle Therapy Breakdown Data by Application
5.1 Global Targeted Alpha-particle Therapy Historic Market Size by Application (2021–2026)
5.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Targeted Alpha-particle Therapy Market Size (2021–2032)
6.2 North America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Targeted Alpha-particle Therapy Market Size by Country (2021–2026)
6.4 North America Targeted Alpha-particle Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Alpha-particle Therapy Market Size (2021–2032)
7.2 Europe Targeted Alpha-particle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Targeted Alpha-particle Therapy Market Size by Country (2021–2026)
7.4 Europe Targeted Alpha-particle Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Targeted Alpha-particle Therapy Market Size (2021–2032)
8.2 Asia-Pacific Targeted Alpha-particle Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Targeted Alpha-particle Therapy Market Size (2021–2032)
9.2 Latin America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Targeted Alpha-particle Therapy Market Size by Country (2021–2026)
9.4 Latin America Targeted Alpha-particle Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Alpha-particle Therapy Market Size (2021–2032)
10.2 Middle East & Africa Targeted Alpha-particle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Alpha-particle Therapy Introduction
11.1.4 Bayer Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.1.5 Bayer Recent Development
11.2 Orano Med
11.2.1 Orano Med Company Details
11.2.2 Orano Med Business Overview
11.2.3 Orano Med Targeted Alpha-particle Therapy Introduction
11.2.4 Orano Med Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.2.5 Orano Med Recent Development
11.3 Oncoinvent AS
11.3.1 Oncoinvent AS Company Details
11.3.2 Oncoinvent AS Business Overview
11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Introduction
11.3.4 Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.3.5 Oncoinvent AS Recent Development
11.4 Perspective Therapeutics
11.4.1 Perspective Therapeutics Company Details
11.4.2 Perspective Therapeutics Business Overview
11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Introduction
11.4.4 Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.4.5 Perspective Therapeutics Recent Development
11.5 Ablaze Pharma
11.5.1 Ablaze Pharma Company Details
11.5.2 Ablaze Pharma Business Overview
11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Introduction
11.5.4 Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.5.5 Ablaze Pharma Recent Development
11.6 ARTBIO
11.6.1 ARTBIO Company Details
11.6.2 ARTBIO Business Overview
11.6.3 ARTBIO Targeted Alpha-particle Therapy Introduction
11.6.4 ARTBIO Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.6.5 ARTBIO Recent Development
11.7 Fusion Pharmaceuticals(AstraZeneca)
11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Details
11.7.2 Fusion Pharmaceuticals(AstraZeneca) Business Overview
11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Introduction
11.7.4 Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.7.5 Fusion Pharmaceuticals(AstraZeneca) Recent Development
11.8 AlphaGen Therapeutics
11.8.1 AlphaGen Therapeutics Company Details
11.8.2 AlphaGen Therapeutics Business Overview
11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Introduction
11.8.4 AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2021–2026)
11.8.5 AlphaGen Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Actinium-225
Table 3. Key Players of Astatine-211
Table 4. Key Players of Lead-212
Table 5. Key Players of Bismuth-213
Table 6. Key Players of Others
Table 7. Global Targeted Alpha-particle Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2021–2026
Table 10. Global Targeted Alpha-particle Therapy Market Share by Region (2021–2026)
Table 11. Global Targeted Alpha-particle Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Targeted Alpha-particle Therapy Market Share by Region (2027–2032)
Table 13. Targeted Alpha-particle Therapy Market Trends
Table 14. Targeted Alpha-particle Therapy Market Drivers
Table 15. Targeted Alpha-particle Therapy Market Challenges
Table 16. Targeted Alpha-particle Therapy Market Restraints
Table 17. Global Targeted Alpha-particle Therapy Revenue by Players (US$ Million), 2021–2026
Table 18. Global Targeted Alpha-particle Therapy Market Share by Players (2021–2026)
Table 19. Global Top Targeted Alpha-particle Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Alpha-particle Therapy Revenue, 2025
Table 20. Ranking of Global Top Targeted Alpha-particle Therapy Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Targeted Alpha-particle Therapy Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Targeted Alpha-particle Therapy, Headquarters and Area Served
Table 23. Global Key Players of Targeted Alpha-particle Therapy, Products and Applications
Table 24. Global Key Players of Targeted Alpha-particle Therapy, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Targeted Alpha-particle Therapy Market Size by Type (US$ Million), 2021–2026
Table 27. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2021–2026)
Table 28. Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2027–2032)
Table 30. Global Targeted Alpha-particle Therapy Market Size by Application (US$ Million), 2021–2026
Table 31. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2021–2026)
Table 32. Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2027–2032)
Table 34. North America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. North America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Targeted Alpha-particle Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (US$ Million), 2027–2032
Table 49. Bayer Company Details
Table 50. Bayer Business Overview
Table 51. Bayer Targeted Alpha-particle Therapy Product
Table 52. Bayer Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 53. Bayer Recent Development
Table 54. Orano Med Company Details
Table 55. Orano Med Business Overview
Table 56. Orano Med Targeted Alpha-particle Therapy Product
Table 57. Orano Med Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 58. Orano Med Recent Development
Table 59. Oncoinvent AS Company Details
Table 60. Oncoinvent AS Business Overview
Table 61. Oncoinvent AS Targeted Alpha-particle Therapy Product
Table 62. Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 63. Oncoinvent AS Recent Development
Table 64. Perspective Therapeutics Company Details
Table 65. Perspective Therapeutics Business Overview
Table 66. Perspective Therapeutics Targeted Alpha-particle Therapy Product
Table 67. Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 68. Perspective Therapeutics Recent Development
Table 69. Ablaze Pharma Company Details
Table 70. Ablaze Pharma Business Overview
Table 71. Ablaze Pharma Targeted Alpha-particle Therapy Product
Table 72. Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 73. Ablaze Pharma Recent Development
Table 74. ARTBIO Company Details
Table 75. ARTBIO Business Overview
Table 76. ARTBIO Targeted Alpha-particle Therapy Product
Table 77. ARTBIO Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 78. ARTBIO Recent Development
Table 79. Fusion Pharmaceuticals(AstraZeneca) Company Details
Table 80. Fusion Pharmaceuticals(AstraZeneca) Business Overview
Table 81. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product
Table 82. Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 83. Fusion Pharmaceuticals(AstraZeneca) Recent Development
Table 84. AlphaGen Therapeutics Company Details
Table 85. AlphaGen Therapeutics Business Overview
Table 86. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product
Table 87. AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (US$ Million), 2021–2026
Table 88. AlphaGen Therapeutics Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Targeted Alpha-particle Therapy Picture
Figure 2. Global Targeted Alpha-particle Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Alpha-particle Therapy Market Share by Type: 2025 vs 2032
Figure 4. Actinium-225 Features
Figure 5. Astatine-211 Features
Figure 6. Lead-212 Features
Figure 7. Bismuth-213 Features
Figure 8. Others Features
Figure 9. Global Targeted Alpha-particle Therapy Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Targeted Alpha-particle Therapy Market Share by Application: 2025 vs 2032
Figure 11. Immunotherapy Case Studies
Figure 12. Peritoneal Carcinomas Case Studies
Figure 13. Bone Metastases Case Studies
Figure 14. Leukaemia Case Studies
Figure 15. Melanomas Case Studies
Figure 16. Solid Tumours Case Studies
Figure 17. Targeted Alpha-particle Therapy Report Years Considered
Figure 18. Global Targeted Alpha-particle Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Targeted Alpha-particle Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Targeted Alpha-particle Therapy Market Share by Region: 2025 vs 2032
Figure 21. Global Targeted Alpha-particle Therapy Market Share by Players in 2025
Figure 22. Global Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Targeted Alpha-particle Therapy Revenue in 2025
Figure 24. North America Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 26. United States Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 30. Germany Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Targeted Alpha-particle Therapy Market Share by Region (2021–2032)
Figure 38. China Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 46. Mexico Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Targeted Alpha-particle Therapy Market Share by Country (2021–2032)
Figure 50. Israel Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Targeted Alpha-particle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Bayer Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 54. Orano Med Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 55. Oncoinvent AS Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 56. Perspective Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 57. Ablaze Pharma Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 58. ARTBIO Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 59. Fusion Pharmaceuticals(AstraZeneca) Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 60. AlphaGen Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
